BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11239793)

  • 41. The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering.
    Kolovou G
    Curr Med Res Opin; 2001; 17(1):34-7. PubMed ID: 11464443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins: a treatment option for chronic heart failure?
    von Haehling S; Okonko DO; Anker SD
    Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
    J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages.
    Huang KC; Chen CW; Chen JC; Lin WW
    J Biomed Sci; 2003; 10(4):396-405. PubMed ID: 12824699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of HMG-CoA reductase inhibitors on endothelial function.
    Tesfamariam B
    Am J Cardiovasc Drugs; 2006; 6(2):115-20. PubMed ID: 16555864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Wieland H
    Herz; 2000 Mar; 25(2):117-25. PubMed ID: 10829251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
    Arnaud C; Mach F
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins and stroke.
    Rodríguez-Yáñez M; Agulla J; Rodríguez-González R; Sobrino T; Castillo J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):157-66. PubMed ID: 19124419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease.
    Järvisalo MJ; Toikka JO; Vasankari T; Mikkola J; Viikari JS; Hartiala JJ; Raitakari OT
    Atherosclerosis; 1999 Dec; 147(2):237-42. PubMed ID: 10559508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
    Lefer AM; Scalia R; Lefer DJ
    Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
    [No Abstract]   [Full Text] [Related]  

  • 54. Non-lipid-related effects of statins.
    Bellosta S; Ferri N; Bernini F; Paoletti R; Corsini A
    Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins: effects beyond cholesterol lowering.
    Massy ZA; Guijarro C
    Nephrol Dial Transplant; 2001 Sep; 16(9):1738-41. PubMed ID: 11522848
    [No Abstract]   [Full Text] [Related]  

  • 56. The acute (cerebro)vascular effects of statins.
    Prinz V; Endres M
    Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective properties of statins.
    Stepień K; Tomaszewski M; Czuczwar SJ
    Pharmacol Rep; 2005; 57(5):561-9. PubMed ID: 16227638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspectives on the cardioprotective effects of statins.
    Luo JD; Chen AF
    Curr Med Chem; 2003 Aug; 10(16):1593-601. PubMed ID: 12871130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.